4 | SEC Filings Hub

Filing metadata

Accession number: 0001127602-22-002062
Form type: Form 4
Filer: Apellis Pharmaceuticals, Inc.
CIK: CIK 1492422
Filed: Jan 25, 2022
Reporting period: Jan 21, 2022
Description: Insider transaction

Documents

0001127602-22-002062-index.htm

Complete submission

0001127602-22-002062.txt

directory listing

Filed by

Apellis Pharmaceuticals, Inc.